Dr. Jonathan Ari Cabin, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1525 Wilson Blvd Ste 125, Arlington, VA 22209 Phone: 703-214-6496 Fax: 844-357-7049 |
Candice Kremer, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1635 N George Mason Dr Ste 250, Arlington, VA 22205 Phone: 703-524-1212 |
Dr. Mohammad Zafar Iqbal, M.D., Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1715 N George Mason Dr, #202, Arlington, VA 22205 Phone: 703-522-0137 Fax: 703-522-4687 |
Dr. Jae Y Kim, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2200 Wilson Blvd Ste 102-219, Arlington, VA 22201 Phone: 347-551-1113 |
Dr. Thomas Michael Pilkington, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1635 N George Mason Dr, Suite 250, Arlington, VA 22205 Phone: 703-524-1212 Fax: 703-524-4595 |
Dr. Scott D. Spagnoli, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1635 N George Mason Dr, Ste. 250, Arlington, VA 22205 Phone: 703-524-1212 Fax: 703-524-4595 |
News Archive
Researchers at Huntsman Cancer Institute, in collaboration with a worldwide group of physicians and scientists, have discovered a remarkable treatment for a rare, yet debilitating, skin condition.
Karen Handel says she is leaving immediately so the organization can "refocus" on its mission, after becoming a lightning rod for controversy over its decision to cut funds to Planned Parenthood.
GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) (http://www.geckosystems.com/) announced today that they are very pleased with the recent press coverage they have received from Forbes.com and other notable online authors. GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Serviceā¢."
Emergency medicine carries a deep aura of romance in America, with its first-responder traditions of adrenaline, acuity and bravery.
The strategy of using monoclonal antibodies for cancer treatment was first described in the late 1970s with the promise that they could be developed into therapies that were highly specific to cancer cells, killing them with few or no side effects.
› Verified 5 days ago